DAVID PLATT
CIK 1166440 · CEO · last filed 2025-11-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
39
Lifetime Open-Market Net
$230
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC (PRW) Delisted | Chairman & CEO | 1,000 | — | — | $230 | 4 | 2008-09-22 |
Recent Filings · Page 4 of 4
39 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-12-31 | — | Buy (P) | −3,000 | -$1.9K | |
| 2012-06-12 | — | Buy (P) | +1,985 | $1.8K | |
| 2012-03-26 | — | Sell (S) | −160,000 | -$40.0K | |
| 2009-03-20 | — | Buy (P) | +26,300 | $5.3K | |
| 2009-03-20 | — | Buy (P) | +11,667 | $0 | |
| 2008-09-22 | GALECTIN THERAPEUTICS INC (PRW) Delisted | Buy (P) | +1,000 | $230 | EDGAR |
| 2008-04-14 | GALECTIN THERAPEUTICS INC (PRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-10-12 | GALECTIN THERAPEUTICS INC (PRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-13 | GALECTIN THERAPEUTICS INC (PRW) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–39 of 39
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.